These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15101389)

  • 1. Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities.
    Greer IA
    Thromb Haemost; 2004 Apr; 91(4):636-8. PubMed ID: 15101389
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome.
    Dignat-George F; Camoin-Jau L; Sabatier F; Arnoux D; Anfosso F; Bardin N; Veit V; Combes V; Gentile S; Moal V; Sanmarco M; Sampol J
    Thromb Haemost; 2004 Apr; 91(4):667-73. PubMed ID: 15045126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental thrombosis and antiphospholipid antibodies: new insights.
    Pierangeli SS; Gharavi AE; Harris EN
    J Autoimmun; 2000 Sep; 15(2):241-7. PubMed ID: 10968918
    [No Abstract]   [Full Text] [Related]  

  • 4. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
    Pericleous C; Giles I; Rahman A
    Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating endothelial microparticles: a new marker of vascular injury].
    Boulanger CM; Leroyer AS; Amabile N; Tedgui A
    Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response and the endothelium.
    Meroni PL; Borghi MO; Raschi E; Ventura D; Sarzi Puttini PC; Atzeni F; Lonati L; Parati G; Tincani A; Mari D; Tedesco F
    Thromb Res; 2004; 114(5-6):329-34. PubMed ID: 15507262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics.
    Corban MT; Duarte-Garcia A; McBane RD; Matteson EL; Lerman LO; Lerman A
    J Am Coll Cardiol; 2017 May; 69(18):2317-2330. PubMed ID: 28473138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiphospholipid syndrome: an update.
    Franchini M
    Clin Lab; 2006; 52(1-2):11-7. PubMed ID: 16506359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome.
    Duval A; Darnige L; Glowacki F; Copin MC; Martin De Lassalle E; Delaporte E; Auxenfants E
    J Am Acad Dermatol; 2009 Dec; 61(6):1076-8. PubMed ID: 19646781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiphospholipid syndrome and endothelial function.
    Blum A; Simsolo C
    Isr Med Assoc J; 2004 Sep; 6(9):556-8. PubMed ID: 15373316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
    Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PATIENTS WITH HAVE A LEVEL OF ENDOTHELIN-1 AN ANTIFOSFOLIPID SYNDROME: CONNECTION IS WITH MOTION OF DISEASE, DISFUNCTION OF ENDOTHELIA AND ATHEROSCLEROSIS].
    Kuvikova I; Shevchuk S
    Lik Sprava; 2014 Dec; (12):26-33. PubMed ID: 26638464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial function: cardiac events.
    Lerman A; Zeiher AM
    Circulation; 2005 Jan; 111(3):363-8. PubMed ID: 15668353
    [No Abstract]   [Full Text] [Related]  

  • 15. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function.
    Klinkner DB; Densmore JC; Kaul S; Noll L; Lim HJ; Weihrauch D; Pritchard KA; Oldham KT; Sander TL
    Shock; 2006 Jun; 25(6):575-80. PubMed ID: 16721264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies.
    Pierangeli SS; Vega-Ostertag M; Harris EN
    Thromb Res; 2004; 114(5-6):467-76. PubMed ID: 15507280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies.
    Dunoyer-Geindre S; Kruithof EK; Boehlen F; Satta-Poschung N; Reber G; de Moerloose P
    J Thromb Haemost; 2004 Jul; 2(7):1176-81. PubMed ID: 15219202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
    Alessandri C; Sorice M; Bombardieri M; Conigliaro P; Longo A; Garofalo T; Manganelli V; Conti F; Esposti MD; Valesini G
    Arthritis Res Ther; 2006; 8(6):R180. PubMed ID: 17150088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.